{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:36:10Z","timestamp":1792427770465,"version":"4.5.0"},"reference-count":413,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.anai.2023.10.032","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:17:44Z","timestamp":1699575464000},"page":"440-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation"],"prefix":"10.1016","volume":"132","author":[{"given":"Theoharis C.","family":"Theoharides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assma","family":"Twahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duraisamy","family":"Kempuraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0001","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2012.07.003","article-title":"Developmental origin and functional specialization of mast cell subsets","volume":"37","author":"Gurish","year":"2012","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0002","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"Olivera","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0004","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jaip.2022.05.007","article-title":"Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium","volume":"10","author":"Valent","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2023.2200936","article-title":"Mast cell activation: beyond histamine and tryptase","volume":"19","author":"Theoharides","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"4-5","key":"10.1016\/j.anai.2023.10.032_bib0006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0344-0338(85)80184-9","article-title":"Tissue mast cells in health and disease","volume":"179","author":"Parwaresch","year":"1985","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1556\/030.62.2015.3.1","article-title":"Mast cell, the peculiar member of the immune system: a homeostatic aspect","volume":"62","author":"Csaba","year":"2015","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0008","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","article-title":"Mast cells as drivers of disease and therapeutic targets","volume":"39","author":"Siebenhaar","year":"2018","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0009","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2125.1986.tb05233.x","article-title":"Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria","volume":"21","author":"Phillips","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.anai.2023.10.032_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107718","article-title":"Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications","volume":"220","author":"Falduto","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/all.14881","article-title":"The ingenious mast cell: contemporary insights into mast cell behavior and function","volume":"77","author":"Dahlin","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0012","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-021-00622-y","article-title":"Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases","volume":"22","author":"Kolkhir","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0013","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jaci.2022.01.030","article-title":"Selected recent advances in understanding the role of human mast cells in health and disease","volume":"149","author":"Levi-Schaffer","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0014","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/eji.201444546","article-title":"Mast cell activation: a complex interplay of positive and negative signaling pathways","volume":"44","author":"Sibilano","year":"2014","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0015","first-page":"1","article-title":"Interleukin-1 family cytokines and mast cells: activation and inhibition","volume":"33","author":"Gallenga","year":"2019","journal-title":"J Biol Regul Homeost Agents"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0016","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ACI.0b013e32832e9af1","article-title":"Mast cells: makers and breakers of allergic inflammation","volume":"9","author":"Hakim-Rad","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0018","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/1073858419848293","article-title":"Brain injury-mediated neuroinflammatory response and Alzheimer's disease","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"issue":"7203","key":"10.1016\/j.anai.2023.10.032_bib0019","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07204","article-title":"The development of allergic inflammation","volume":"454","author":"Galli","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12634","article-title":"Mast cells as sources of cytokines, chemokines, and growth factors","volume":"282","author":"Mukai","year":"2018","journal-title":"Immunol Rev"},{"issue":"40","key":"10.1016\/j.anai.2023.10.032_bib0021","doi-asserted-by":"crossref","first-page":"E9381","DOI":"10.1073\/pnas.1810133115","article-title":"Substance P and IL-33 administered together stimulate a marked secretion of IL-1beta from human mast cells, inhibited by methoxyluteolin","volume":"115","author":"Taracanova","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0022","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.4049\/jimmunol.171.9.4830","article-title":"IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells","volume":"171","author":"Kandere-Grzybowska","year":"2003","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0023","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2500\/aap.2018.38.4105","article-title":"Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and\/or immunoglobulin E","volume":"39","author":"Petra","year":"2018","journal-title":"Allergy Asthma Proc"},{"issue":"20","key":"10.1016\/j.anai.2023.10.032_bib0024","doi-asserted-by":"crossref","first-page":"E4002","DOI":"10.1073\/pnas.1524845114","article-title":"SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors","volume":"114","author":"Taracanova","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0026","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000524532","article-title":"Mast cell activation syndromes: collegium internationale Allergologicum update 2022","volume":"183","author":"Valent","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41571-021-00592-z","article-title":"A new standard for mastocytosis","volume":"19","author":"Killock","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0028","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/ijms22062983","article-title":"Response criteria in advanced systemic mastocytosis: evolution in the era of KIT inhibitors","volume":"22","author":"Shomali","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0029","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.3390\/ijms22094900","article-title":"New insights into the pathogenesis of systemic mastocytosis","volume":"22","author":"Li","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anai.2023.10.032_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fnins.2015.00225","article-title":"Brain \u201cfog,\u201d inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin","volume":"9","author":"Theoharides","year":"2015","journal-title":"Front Neurosci"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0031","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/cells12050688","article-title":"Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID","volume":"12","author":"Theoharides","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0032","doi-asserted-by":"crossref","first-page":"e39468","DOI":"10.1371\/journal.pone.0039468","article-title":"Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression","volume":"7","author":"Moura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.anai.2023.10.032_bib0033","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbi.2015.07.002","article-title":"Mast cell activation disease: an underappreciated cause of neurologic and psychiatric symptoms and diseases","volume":"50","author":"Afrin","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0034","doi-asserted-by":"crossref","first-page":"e12093","DOI":"10.1002\/clt2.12093","article-title":"Mastocytosis patients\u2019 cognitive dysfunctions correlate with the presence of spindle-shaped mast cells in bone marrow","volume":"12","author":"Spolak-Bobryk","year":"2022","journal-title":"Clin Transl Allergy"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0035","doi-asserted-by":"crossref","first-page":"e1197","DOI":"10.1038\/tp.2017.137","article-title":"Neuroimaging evidence of brain abnormalities in mastocytosis","volume":"7","author":"Boddaert","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0036","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.jcp.0000193483.89260.a7","article-title":"Chronic fatigue syndrome, mast cells, and tricyclic antidepressants","volume":"25","author":"Theoharides","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0037","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","article-title":"Mast cells as targets of corticotropin-releasing factor and related peptides","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"6281","key":"10.1016\/j.anai.2023.10.032_bib0038","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/346274a0","article-title":"Mast cells as a source of both preformed and immunologically inducible TNF-alpha\/cachectin","volume":"346","author":"Gordon","year":"1990","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0039","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2011.02.005","article-title":"Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis","volume":"127","author":"Zhang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0040","doi-asserted-by":"crossref","first-page":"e49767","DOI":"10.1371\/journal.pone.0049767","article-title":"Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0041","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1189\/jlb.0703328","article-title":"Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses","volume":"75","author":"Collins","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0042","doi-asserted-by":"crossref","first-page":"e59989","DOI":"10.1371\/journal.pone.0059989","article-title":"Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.anai.2023.10.032_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172760","article-title":"IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-kappaB, inhibited by methoxyluteolin","volume":"865","author":"Bawazeer","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0044","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood.V89.8.2654","article-title":"Differential release of mast cell interleukin-6 via c-kit","volume":"89","author":"Gagari","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000063858","article-title":"Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients","volume":"128","author":"Theoharides","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0046","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clim.2005.01.011","article-title":"IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis","volume":"115","author":"Brockow","year":"2005","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0047","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/leu.2015.176","article-title":"Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression","volume":"30","author":"Mayado","year":"2016","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0048","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/all.12593","article-title":"IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk","volume":"70","author":"Kaur","year":"2015","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0049","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nri2782","article-title":"Mast cell-orchestrated immunity to pathogens","volume":"10","author":"Abraham","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.798660","article-title":"Mast cell activation triggered by retrovirus promotes acute viral infection","volume":"13","author":"Song","year":"2022","journal-title":"Front Microbiol"},{"issue":"18","key":"10.1016\/j.anai.2023.10.032_bib0051","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.3390\/ijms231810864","article-title":"The role of TGF\u03b2 and other cytokines in regulating mast cell functions in allergic inflammation","volume":"23","author":"Haque","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0052","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/biof.1464","article-title":"Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33","volume":"45","author":"Gross","year":"2019","journal-title":"BioFactors"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0053","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.3390\/ijms24054811","article-title":"Activation of mast cells by neuropeptides: the role of pro-inflammatory and anti-inflammatory cytokines","volume":"24","author":"Lauritano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anai.2023.10.032_bib0054","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2015.07.017","article-title":"Non-IgE mediated mast cell activation","volume":"778","author":"Yu","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaci.2018.09.014","article-title":"Effect of IL-33 on de novo synthesized mediators from human mast cells","volume":"143","author":"Theoharides","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0056","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/exd.13288","article-title":"Neuroendocrinology of mast cells: challenges and controversies","volume":"26","author":"Theoharides","year":"2017","journal-title":"Exp Dermatol"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0057","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1073\/pnas.1000803107","article-title":"IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin","volume":"107","author":"Theoharides","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0058","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2014.07.036","article-title":"Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses","volume":"135","author":"Sumpter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"22","key":"10.1016\/j.anai.2023.10.032_bib0059","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","article-title":"Neuropeptide substance P and the immune response","volume":"73","author":"Mashaghi","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","article-title":"The role of substance P in inflammatory disease","volume":"201","author":"O'Connor","year":"2004","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0061","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.0954-6820.2000.00773.x","article-title":"Substance P: a pioneer amongst neuropeptides","volume":"249","author":"Hokfelt","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.anai.2023.10.032_bib0062","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.2010.05826.x","article-title":"Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation","volume":"1217","author":"Douglas","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0063","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.1601751","article-title":"Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis","volume":"199","author":"Suvas","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0064","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13601-015-0076-5","article-title":"The role of IL-33 and mast cells in allergy and inflammation","volume":"5","author":"Saluja","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2023.10.032_bib0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"Theoharides","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.anai.2023.10.032_bib0066","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fncel.2019.00353","article-title":"Mast cells, neuroinflammation and pain in fibromyalgia syndrome","volume":"13","author":"Theoharides","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0067","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12974-020-02029-3","article-title":"Neurotransmitter and neuropeptide regulation of mast cell function: a systematic review","volume":"17","author":"Xu","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0068","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0166-2236(96)10058-8","article-title":"Nerve growth factor: from neurotrophin to neurokine","volume":"19","author":"Levi-Montalcini","year":"1996","journal-title":"Trends Neurosci"},{"issue":"20","key":"10.1016\/j.anai.2023.10.032_bib0069","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1073\/pnas.0602210103","article-title":"Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process","volume":"103","author":"Donelan","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(81)90407-6","article-title":"Somatostatin-induced histamine secretion in mast cells. Characterization of the effect","volume":"69","author":"Theoharides","year":"1981","journal-title":"Eur J Pharmacol"},{"issue":"2-3","key":"10.1016\/j.anai.2023.10.032_bib0071","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(81)90084-4","article-title":"Mast cell histamine secretion in response to somatostatin analogues: structural considerations","volume":"73","author":"Theoharides","year":"1981","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0072","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cells10051033","article-title":"Unlocking the non-IgE-mediated pseudo-allergic reaction puzzle with Mas-related G-protein coupled receptor member X2 (MRGPRX2)","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0073","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.iac.2021.12.003","article-title":"Mas-related G protein-coupled receptor-X2 and its role in non-immunoglobulin E-mediated drug hypersensitivity","volume":"42","author":"Chompunud Na Ayudhya","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0074","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaci.2021.03.049","article-title":"Multifaceted MRGPRX2: new insight into the role of mast cells in health and disease","volume":"148","author":"Roy","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1042\/BST20170450","article-title":"Diverse exocytic pathways for mast cell mediators","volume":"46","author":"Xu","year":"2018","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0076","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nri1782","article-title":"Integrated signalling pathways for mast-cell activation","volume":"6","author":"Gilfillan","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0077","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI85538","article-title":"Different activation signals induce distinct mast cell degranulation strategies","volume":"126","author":"Gaudenzio","year":"2016","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0078","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.anai.2020.07.007","article-title":"The impact of psychological stress on mast cells","volume":"125","author":"Theoharides","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0079","first-page":"65","article-title":"Significance of conversation between mast cells and nerves","volume":"1","author":"Kleij","year":"2005","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1-2","key":"10.1016\/j.anai.2023.10.032_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01855-7","article-title":"Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo","volume":"849","author":"Rozniecki","year":"1999","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0081","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.clinthera.2016.02.030","article-title":"Nanotube formation: a rapid form of \u201calarm signaling\u201d?","volume":"38","author":"Weng","year":"2016","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0082","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jcp.40.1.9","article-title":"Mast cells in the human carotid body","volume":"40","author":"Heath","year":"1987","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0083","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1540-8183.2007.00283.x","article-title":"Coronary stents, hypersensitivity reactions, and the Kounis syndrome","volume":"20","author":"Kounis","year":"2007","journal-title":"J Interv Cardiol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0084","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.4049\/jimmunol.154.6.2855","article-title":"Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization","volume":"154","author":"Patella","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0085","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10238-022-00861-w","article-title":"Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells","volume":"23","author":"Poto","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.anai.2023.10.032_bib0086","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4939-1568-2_9","article-title":"The parasympathetic nervous system as a regulator of mast cell function","volume":"1220","author":"Forsythe","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"1-2","key":"10.1016\/j.anai.2023.10.032_bib0087","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.autneu.2006.01.002","article-title":"Vagal influences over mast cells","volume":"125","author":"Stead","year":"2006","journal-title":"Auton Neurosci"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0088","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1254\/jjp.85.2","article-title":"The biological role of non-neuronal acetylcholine in plants and humans","volume":"85","author":"Wessler","year":"2001","journal-title":"Jpn J Pharmacol"},{"issue":"18-19","key":"10.1016\/j.anai.2023.10.032_bib0089","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0024-3205(03)00079-1","article-title":"Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis","volume":"72","author":"Wessler","year":"2003","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.alit.2020.05.006","article-title":"Direct and indirect action modes of acetylcholine in cholinergic urticaria","volume":"70","author":"Tokura","year":"2021","journal-title":"Allergol Int"},{"issue":"5662","key":"10.1016\/j.anai.2023.10.032_bib0091","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/273473a0","article-title":"Release of histamine from rat mast cells by acetylcholine","volume":"273","author":"Fantozzi","year":"1978","journal-title":"Nature"},{"issue":"special no","key":"10.1016\/j.anai.2023.10.032_bib0092","doi-asserted-by":"crossref","first-page":"C32","DOI":"10.1007\/BF02007754","article-title":"The mechanism of histamine release induced by pilocarpine from different tissues: studies on rat peritoneal mast cells","volume":"41","author":"Erjavec","year":"1994","journal-title":"Agents Actions"},{"issue":"1 Pt 2","key":"10.1016\/j.anai.2023.10.032_bib0093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02024170","article-title":"Failure of acetylcholine to release histamine from rat mast cells","volume":"10","author":"Kazimierczak","year":"1980","journal-title":"Agents Actions"},{"issue":"3-4","key":"10.1016\/j.anai.2023.10.032_bib0094","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF01973831","article-title":"The interaction of cholinomimetics, peptides and compounds 48\/80 on histamine secretion from the mast cell","volume":"14","author":"Erjavec","year":"1984","journal-title":"Agents Actions"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0162-3109(81)90005-9","article-title":"Evaluation of the action of cholinergic agonists and cyclic guanosine monophosphate (c'GMP) on histamine release from purified rat mast cells","volume":"3","author":"Hanna","year":"1981","journal-title":"Immunopharmacology"},{"issue":"2 Pt 1","key":"10.1016\/j.anai.2023.10.032_bib0096","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1164\/ajrccm.156.2.96-12079","article-title":"Acetylcholine via muscarinic receptors inhibits histamine release from human isolated bronchi","volume":"156","author":"Reinheimer","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0097","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2008.10.004","article-title":"IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors","volume":"377","author":"Kageyama-Yahara","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.anai.2023.10.032_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631881","article-title":"New pathways for the skin's stress response: the cholinergic neuropeptide SLURP-1 can activate mast cells and alter cytokine production in mice","volume":"12","author":"Ertle","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0099","doi-asserted-by":"crossref","first-page":"e85888","DOI":"10.1371\/journal.pone.0085888","article-title":"Anti-allergic role of cholinergic neuronal pathway via \u03b17 nicotinic ACh receptors on mucosal mast cells in a murine food allergy model","volume":"9","author":"Yamamoto","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.0902227","article-title":"Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7\/alpha 9\/alpha 10-nicotinic receptors","volume":"185","author":"Mishra","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00505481","article-title":"Presence of functionally active beta-adrenoceptors in rat mast cells. Correlation between (\u2013)[3H]-dihydroalprenolol binding and inhibition of histamine release","volume":"321","author":"Masini","year":"1982","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0102","doi-asserted-by":"crossref","first-page":"e12699","DOI":"10.1111\/jpi.12699","article-title":"The interplay between mast cells, pineal gland, and circadian rhythm: links between histamine, melatonin, and inflammatory mediators","volume":"70","author":"Pham","year":"2021","journal-title":"J Pineal Res"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbi.2010.09.007","article-title":"A circadian clock in murine bone marrow-derived mast cells modulates IgE-dependent activation in vitro","volume":"25","author":"Wang","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0104","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.alit.2017.02.004","article-title":"Clock-dependent temporal regulation of IL-33\/ST2-mediated mast cell response","volume":"66","author":"Kawauchi","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.anai.2023.10.032_bib0105","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fimmu.2018.01526","article-title":"The circadian clock drives mast cell functions in allergic reactions","volume":"9","author":"Christ","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1003431122334","article-title":"Extrapineal melatonin: location and role within diffuse neuroendocrine system","volume":"31","author":"Kvetnoy","year":"1999","journal-title":"Histochem J"},{"issue":"81","key":"10.1016\/j.anai.2023.10.032_bib0107","doi-asserted-by":"crossref","first-page":"eadc9417","DOI":"10.1126\/sciimmunol.adc9417","article-title":"A mast cell-thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis","volume":"8","author":"Bao","year":"2023","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0108","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00421-021-04645-0","article-title":"Histamine, mast cell tryptase and post-exercise hypotension in healthy and collapsed marathon runners","volume":"121","author":"Parsons","year":"2021","journal-title":"Eur J Appl Physiol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0109","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.anai.2021.10.006","article-title":"Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy","volume":"128","author":"Novak","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0024-3205(90)90129-F","article-title":"Mast cells: the immune gate to the brain","volume":"46","author":"Theoharides","year":"1990","journal-title":"Life Sci"},{"issue":"s1","key":"10.1016\/j.anai.2023.10.032_bib0111","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.3233\/JIN-170068","article-title":"Mast cells in the brain - old cells, new target","volume":"16","author":"Traina","year":"2017","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0112","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-015-0388-3","article-title":"Mast cells in meningiomas and brain inflammation","volume":"12","author":"Polyzoidis","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0113","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0306-4522(95)00606-0","article-title":"Definitive characterization of rat hypothalamic mast cells","volume":"73","author":"Pang","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.anai.2023.10.032_bib0114","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2741\/2174","article-title":"Corticotropin-releasing hormone and the blood-brain-barrier","volume":"12","author":"Theoharides","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0116","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.27.9.878","article-title":"Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain","volume":"27","author":"Edvinsson","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.anai.2023.10.032_bib0117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0074-7696(08)61396-0","article-title":"Mast cells in the nervous system","volume":"24","author":"Olsson","year":"1968","journal-title":"Int Rev Cytol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0118","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-0404.1974.tb02806.x","article-title":"Mast cells in plaques of multiple sclerosis","volume":"50","author":"Olsson","year":"1974","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0119","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1990.tb00927.x","article-title":"Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures","volume":"81","author":"Kruger","year":"1990","journal-title":"Acta Neurol Scand"},{"issue":"2-3","key":"10.1016\/j.anai.2023.10.032_bib0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-5728(90)90101-R","article-title":"Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains","volume":"30","author":"Toms","year":"1990","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ana.410370112","article-title":"Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients","volume":"37","author":"Rozniecki","year":"1995","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0122","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jaci.2013.04.060","article-title":"Lack of evidence for intrathecal tryptase synthesis in patients with systemic mastocytosis","volume":"132","author":"Smith","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0123","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.194.1.71","article-title":"Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs","volume":"194","author":"Matsumoto","year":"2001","journal-title":"J Exp Med"},{"issue":"suppl 1","key":"10.1016\/j.anai.2023.10.032_bib0124","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/BF01674391","article-title":"Degranulation and decrease in histamine levels of thalamic mast cells coincides with corticosterone secretion induced by compound 48\/80","volume":"44","author":"Bugajski","year":"1995","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1081-1206(10)60717-X","article-title":"Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis","volume":"98","author":"Kalogeromitros","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0126","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0361-9230(00)00299-9","article-title":"Anaphylactoid reactions activate hypothalamo-pituitary-adrenocortical axis: comparison with endotoxic reactions","volume":"52","author":"Foldes","year":"2000","journal-title":"Brain Res Bull"},{"issue":"26","key":"10.1016\/j.anai.2023.10.032_bib0127","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/S0024-3205(00)00899-7","article-title":"Studies on the involvement of histamine in the hypothalamic-pituitary-adrenal axis activation induced by nerve growth factor","volume":"67","author":"Scaccianoce","year":"2000","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0128","first-page":"1212","article-title":"Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man","volume":"79","author":"Spath-Schwalbe","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/en.2003-0805","article-title":"Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells","volume":"145","author":"Kempuraj","year":"2004","journal-title":"Endocrinology"},{"issue":"1-2","key":"10.1016\/j.anai.2023.10.032_bib0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(94)90403-0","article-title":"Opening of the blood-brain barrier during cortical superfusion with histamine","volume":"653","author":"Schilling","year":"1994","journal-title":"Brain Res"},{"issue":"1-3","key":"10.1016\/j.anai.2023.10.032_bib0131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-409X(95)00004-Q","article-title":"Biochemical opening of the blood-brain barrier","volume":"15","author":"Black","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.anai.2023.10.032_bib0132","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/937148","article-title":"Histamine induces Alzheimer's disease-like blood brain barrier breach and local cellular responses in mouse brain organotypic cultures","volume":"2015","author":"Sedeyn","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.anai.2023.10.032_bib0133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1090288","article-title":"Mast cell activation mediates blood-brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway","volume":"14","author":"Yue","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0134","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-018-1287-1","article-title":"Effect of tryptase on mouse brain microvascular endothelial cells via protease-activated receptor 2","volume":"15","author":"Zhou","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007074420772","article-title":"Inflammatory mediators and modulation of blood-brain barrier permeability","volume":"20","author":"Abbott","year":"2000","journal-title":"Cell Mol Neurobiol"},{"issue":"33","key":"10.1016\/j.anai.2023.10.032_bib0136","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2174\/138161211798220918","article-title":"Cytokine signaling modulates blood-brain barrier function","volume":"17","author":"Pan","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0137","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1124\/jpet.102.038497","article-title":"Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress","volume":"303","author":"Esposito","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0138","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/j.1582-4934.2012.01556.x","article-title":"Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation","volume":"16","author":"Sarlus","year":"2012","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0140","first-page":"R1840","article-title":"Blood-borne, albumin-bound prostaglandin E2 may be involved in fever","volume":"276","author":"Romanovsky","year":"1999","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0141","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0306-4522(96)00488-5","article-title":"Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions","volume":"77","author":"Dimitriadou","year":"1997","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0142","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \u2018brain-skin connection","volume":"27","author":"Paus","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0143","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4243953","article-title":"Mast cell activation, neuroinflammation, and tight junction protein derangement in acute traumatic brain injury","volume":"2020","author":"Kempuraj","year":"2020","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0144","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.clinthera.2020.05.002","article-title":"Effect of stress on neuroimmune processes","volume":"42","author":"Theoharides","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2023.10.032_bib0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13229-016-0110-z","article-title":"Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Mol Autism"},{"key":"10.1016\/j.anai.2023.10.032_bib0146","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2010.09.085","article-title":"Brain metastases of mouse mammary adenocarcinoma is increased by acute stress","volume":"1366","author":"Rozniecki","year":"2010","journal-title":"Brain Res"},{"issue":"1-2","key":"10.1016\/j.anai.2023.10.032_bib0147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.09.014","article-title":"Impact of stress and mast cells on brain metastases","volume":"205","author":"Theoharides","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0148","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0006-8993(03)02975-5","article-title":"Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice","volume":"980","author":"Kandere-Grzybowska","year":"2003","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0149","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4049\/jimmunol.1000126","article-title":"Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?","volume":"184","author":"Sayed","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0150","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8098439","article-title":"The mast cell is an early activator of lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in the hippocampus","volume":"2020","author":"Wang","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.anai.2023.10.032_bib0151","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fncel.2019.00054","article-title":"Mast cells in stress, pain, blood-brain barrier, neuroinflammation and Alzheimer's disease","volume":"13","author":"Kempuraj","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0152","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/brv.12750","article-title":"Chronic stress and Alzheimer's disease: the interplay between the hypothalamic-pituitary-adrenal axis, genetics and microglia","volume":"96","author":"Milligan Armstrong","year":"2021","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0153","doi-asserted-by":"crossref","first-page":"e48934","DOI":"10.1371\/journal.pone.0048934","article-title":"Neurotensin and CRH interactions augment human mast cell activation","volume":"7","author":"Alysandratos","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0154","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/jid.2011.334","article-title":"Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells","volume":"132","author":"Asadi","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s000110050459","article-title":"Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells","volume":"48","author":"Okada","year":"1999","journal-title":"Inflamm Res"},{"key":"10.1016\/j.anai.2023.10.032_bib0156","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/7854_2021_253","article-title":"Histamine: a key neuromodulator of memory consolidation and retrieval","volume":"59","author":"Nomura","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0157","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.680214","article-title":"Histamine, neuroinflammation and neurodevelopment: a review","volume":"15","author":"Carthy","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0158","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/7854_2021_249","article-title":"Histamine as an alert signal in the brain","volume":"59","author":"Mochizuki","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0159","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbr.2016.06.051","article-title":"Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases","volume":"312","author":"Sadek","year":"2016","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0160","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/ijms18051082","article-title":"Neurotrauma: the crosstalk between neurotrophins and inflammation in the acutely injured brain","volume":"18","author":"da Silva Meirelles","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anai.2023.10.032_bib0161","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnsys.2012.00051","article-title":"Histamine and motivation","volume":"6","author":"Torrealba","year":"2012","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0162","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/164_2016_12","article-title":"Role of the histamine H3 receptor in the central nervous system","volume":"241","author":"Schlicker","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0164","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bph.14478","article-title":"Brain histamine modulates recognition memory: possible implications in major cognitive disorders","volume":"177","author":"Provensi","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.anai.2023.10.032_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nlm.2017.08.007","article-title":"Histamine regulates memory consolidation","volume":"145","author":"Passani","year":"2017","journal-title":"Neurobiol Learn Mem"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0166","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1523\/JNEUROSCI.0045-10.2010","article-title":"Histamine and orexin in the control of arousal, locomotion, and motivation","volume":"30","author":"Burgess","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0167","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nlm.2013.04.001","article-title":"The role of histamine receptors in the consolidation of object recognition memory","volume":"103","author":"da Silveira","year":"2013","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.anai.2023.10.032_bib0211","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbr.2018.01.011","article-title":"Food allergy induces alteration in brain inflammatory status and cognitive impairments","volume":"364","author":"Zhou","year":"2019","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0168","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12974-016-0592-9","article-title":"Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis","volume":"13","author":"Zhang","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0169","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1159\/000443093","article-title":"Induction of microglial activation by mediators released from mast cells","volume":"38","author":"Zhang","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.17219\/acem\/61914","article-title":"The role of mast cells in Alzheimer's disease","volume":"25","author":"Shaik-Dasthagirisaheb","year":"2016","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0171","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0172","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/jpet.118.250845","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome-metabolic disease or disturbed homeostasis due to focal inflammation in the hypothalamus?","volume":"367","author":"Hatziagelaki","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0173","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00006842-198911000-00001","article-title":"Fifty years and still going strong!","volume":"51","author":"Oken","year":"1989","journal-title":"Psychosom Med"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0174","first-page":"1051","article-title":"Microglia M1\/M2 polarization contributes to electromagnetic pulse-induced brain injury","volume":"33","author":"Zhang","year":"2019","journal-title":"J Biol Regul Homeost Agents"},{"issue":"5-6","key":"10.1016\/j.anai.2023.10.032_bib0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000494761","article-title":"Neuroimmune and inflammatory signals in complex disorders of the central nervous system","volume":"25","author":"Liberman","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.anai.2023.10.032_bib0176","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0177","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","article-title":"Microglia-mediated neuroinflammation in neurodegenerative diseases","volume":"94","author":"Subhramanyam","year":"2019","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0178","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"6301","key":"10.1016\/j.anai.2023.10.032_bib0179","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0180","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0181","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/jnc.14860","article-title":"Microglia and the aging brain: are senescent microglia the key to neurodegeneration?","volume":"151","author":"Angelova","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.anai.2023.10.032_bib0182","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-5-12","article-title":"Microglia in the aging brain: relevance to neurodegeneration","volume":"5","author":"Luo","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0183","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer's disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0184","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1567205016666190321154618","article-title":"Systemic and CNS inflammation crosstalk: implications for Alzheimer's disease","volume":"16","author":"Paouri","year":"2019","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0185","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.175.7.4320","article-title":"TLR signaling tailors innate immune responses in human microglia and astrocytes","volume":"175","author":"Jack","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0186","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fnagi.2018.00314","article-title":"Clinical PET imaging of microglial activation: implications for microglial therapeutics in Alzheimer's disease","volume":"10","author":"Shen","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0188","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1073858418783959","article-title":"Microglia-astrocyte crosstalk: an intimate molecular conversation","volume":"25","author":"Jha","year":"2019","journal-title":"Neuroscientist"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0189","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","article-title":"Microglia-mediated inflammation and neurodegenerative disease","volume":"53","author":"Xu","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1568010053586237","article-title":"Mechanisms of cell signaling and inflammation in Alzheimer's disease","volume":"4","author":"Ho","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0191","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 mediates the innate host response to beta-amyloid","volume":"197","author":"El Khoury","year":"2003","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0192","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0193","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jnr.20477","article-title":"Neurotensin and the neurotensin receptor-3 in microglial cells","volume":"81","author":"Martin","year":"2005","journal-title":"J Neurosci Res"},{"issue":"45","key":"10.1016\/j.anai.2023.10.032_bib0194","doi-asserted-by":"crossref","first-page":"E7049","DOI":"10.1073\/pnas.1604992113","article-title":"Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism","volume":"113","author":"Patel","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.0022-3042.2001.00687.x","article-title":"Functional expression of corticotropin-releasing hormone (CRH) receptor 1 in cultured rat microglia","volume":"80","author":"Wang","year":"2002","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0196","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/npp.2016.185","article-title":"Microglia priming with aging and stress","volume":"42","author":"Niraula","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.anai.2023.10.032_bib0197","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.749737","article-title":"Psychological stress as a risk factor for accelerated cellular aging and cognitive decline: the involvement of microglia-neuron crosstalk","volume":"14","author":"Carrier","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0198","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neubiorev.2017.05.001","article-title":"Mast cells in neuroinflammation and brain disorders","volume":"79","author":"Hendriksen","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0199","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/ijms22031093","article-title":"Decoding mast cell-microglia communication in neurodegenerative diseases","volume":"22","author":"Sandhu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0200","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2174\/1871527313666141130224206","article-title":"Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review","volume":"13","author":"Skaper","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0201","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1073858416687249","article-title":"Neuroinflammation, mast cells, and glia: dangerous liaisons","volume":"23","author":"Skaper","year":"2017","journal-title":"Neuroscientist"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0202","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1096\/fj.11-197194","article-title":"Microglia and mast cells: two tracks on the road to neuroinflammation","volume":"26","author":"Skaper","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.anai.2023.10.032_bib0203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbi.2020.01.013","article-title":"A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice","volume":"87","author":"Selvakumar","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0204","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11481-017-9766-1","article-title":"Cross-talk between glia, neurons and mast cells in neuroinflammation associated with Parkinson's disease","volume":"13","author":"Kempuraj","year":"2018","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0205","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s12035-016-9720-x","article-title":"Suppression of brain mast cells degranulation inhibits microglial activation and central nervous system inflammation","volume":"54","author":"Dong","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0206","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/jpm11090860","article-title":"Ways to Address Perinatal mast cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in autism Spectrum Disorder","volume":"11","author":"Theoharides","year":"2021","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0207","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11481-019-09887-6","article-title":"Histamine induces microglia activation and the release of proinflammatory mediators in rat brain via H1R or H4R","volume":"15","author":"Zhang","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5-6","key":"10.1016\/j.anai.2023.10.032_bib0208","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1159\/000171029","article-title":"Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling","volume":"29","author":"Zhang","year":"2012","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0209","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s12035-018-1177-7","article-title":"Mast cell proteases activate astrocytes and glia-neurons and release interleukin-33 by activating p38 and ERK1\/2 MAPKs and NF-\u03baB","volume":"56","author":"Kempuraj","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.anai.2023.10.032_bib0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2019.00191","article-title":"Stabilization of brain mast cells alleviates LPS-induced neuroinflammation by inhibiting microglia activation","volume":"13","author":"Dong","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.iac.2018.04.004","article-title":"Association of postural tachycardia syndrome and Ehlers-Danlos syndrome with mast cell activation disorders","volume":"38","author":"Bonamichi-Santos","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2500\/aap.2021.42.210022","article-title":"The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome","volume":"42","author":"Wang","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0214","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ajmg.c.31555","article-title":"Mast cell disorders in Ehlers-Danlos syndrome","volume":"175","author":"Seneviratne","year":"2017","journal-title":"Am J Med Genet C"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ajmg.c.31944","article-title":"Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome","volume":"187","author":"Afrin","year":"2021","journal-title":"Am J Med Genet C"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0216","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","article-title":"Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders","volume":"45","author":"Shibao","year":"2005","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0217","doi-asserted-by":"crossref","first-page":"AB65","DOI":"10.1016\/j.jaci.2014.12.1146","article-title":"A new disease cluster: mast cell activation syndrome, postural orthostatic tachycardia syndrome, and Ehlers-Danlos syndrome","volume":"135","author":"Cheung","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0218","first-page":"49","article-title":"Systemic manifestations of Ehlers-Danlos syndrome","volume":"34","author":"Song","year":"2020","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0219","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2006.062224","article-title":"Asthma and airways collapse in two heritable disorders of connective tissue","volume":"66","author":"Morgan","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0221","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15403\/jgld.2014.1121.281.syd","article-title":"Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders","volume":"28","author":"Huang","year":"2019","journal-title":"J Gastrointestin Liver Dis"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0230","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1038\/tp.2016.77","article-title":"Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders","volume":"6","author":"Theoharides","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0255","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/eci.10.18","article-title":"Autism spectrum disorders and allergy: observation from a pediatric allergy\/immunology clinic","volume":"6","author":"Jyonouchi","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"issue":"1-2","key":"10.1016\/j.anai.2023.10.032_bib0254","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2009.09.015","article-title":"Immune allergic response in Asperger syndrome","volume":"216","author":"Magalhaes","year":"2009","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0256","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/aur.1471","article-title":"Hertz-Picciotto I. Asthma and allergies in children with autism spectrum disorders: results from the CHARGE study","volume":"8","author":"Lyall","year":"2015","journal-title":"Autism Res"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0250","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1203\/PDR.0b013e31819e7203","article-title":"Epidemiology of pervasive developmental disorders","volume":"65","author":"Fombonne","year":"2009","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0266","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11882-009-0029-y","article-title":"Food allergy and autism spectrum disorders: is there a link?","volume":"9","author":"Jyonouchi","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0267","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00431-020-03826-x","article-title":"Association of food hypersensitivity in children with the risk of autism spectrum disorder: a meta-analysis","volume":"180","author":"Li","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0883073807307102","article-title":"Autism spectrum disorders: concurrent clinical disorders","volume":"23","author":"Xue","year":"2008","journal-title":"J Child Neurol"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0257","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1007\/s10803-014-2174-y","article-title":"Co-occurrence of autism and asthma in a nationally representative sample of children in the United States","volume":"44","author":"Kotey","year":"2014","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0259","doi-asserted-by":"crossref","first-page":"e15358","DOI":"10.1111\/ped.15358","article-title":"Developmental disorders in school children are related to allergic diseases","volume":"64","author":"Zaitsu","year":"2022","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0258","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40257-015-0145-5","article-title":"Association between atopic dermatitis and autism spectrum disorders: a systematic review","volume":"16","author":"Billeci","year":"2015","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0260","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jdv.18564","article-title":"Atopic dermatitis and risk of major neuropsychiatric disorders in children: a population-based cohort study","volume":"37","author":"Wan","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0261","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13819","article-title":"Early childhood allergy linked with development of attention deficit hyperactivity disorder and autism spectrum disorder","volume":"33","author":"Nemet","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0262","first-page":"1","article-title":"Understanding the relationship between asthma and autism spectrum disorder: a population-based family and twin study","volume":"53","author":"Gong","year":"2022","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0318","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0091-6749(98)70090-9","article-title":"Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables","volume":"102","author":"Borish","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0274","first-page":"120","article-title":"A systematic review of chronic fatigue syndrome: don't assume it's depression. Prim Care Companion","volume":"10","author":"Griffith","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.anai.2023.10.032_bib0366","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2022.06.002","article-title":"Different effectiveness of fungal pathogen-associated molecular patterns (PAMPs) in activating rat peritoneal mast cells","volume":"248","author":"Zelechowska","year":"2022","journal-title":"Immunol Lett"},{"key":"10.1016\/j.anai.2023.10.032_bib0363","article-title":"Signatures of mast cell activation are associated with severe COVID-19","author":"Tan","year":"2021","journal-title":"medRxiv\u202f: the preprint server for health sciences"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0365","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41392-021-00849-0","article-title":"SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury","volume":"6","author":"Wu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"23","key":"10.1016\/j.anai.2023.10.032_bib0370","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0369","doi-asserted-by":"crossref","first-page":"e02025","DOI":"10.1002\/brb3.2025","article-title":"Central nervous system manifestations in COVID-19 patients: a systematic review and meta-analysis","volume":"11","author":"Nazari","year":"2021","journal-title":"Brain Behav"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0362","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/all.15188","article-title":"Mast cell activation is associated with post-acute COVID-19 syndrome","volume":"77","author":"Wechsler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2023.10.032_bib0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.968981","article-title":"Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation","volume":"13","author":"Krysko","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0364","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.574862","article-title":"Mast cells in alveolar septa of COVID-19 patients: a pathogenic pathway that may link interstitial edema to immunothrombosis","volume":"11","author":"Motta Junior","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0220","first-page":"39","article-title":"Joint hypermobility and joint hypermobility syndrome in Iraqi patients with asthma","volume":"2","author":"Al-Rawi","year":"2012","journal-title":"Int J Mod Biol Med"},{"issue":"17","key":"10.1016\/j.anai.2023.10.032_bib0222","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021002","article-title":"Mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association","volume":"10","author":"Kohno","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0223","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12026-022-09280-1","article-title":"Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature","volume":"70","author":"Monaco","year":"2022","journal-title":"Immunol Res"},{"key":"10.1016\/j.anai.2023.10.032_bib411","first-page":"143","article-title":"Ehlers-Danlos Syndrome is associated with Idiopathic Urticaria-a retrospective study [abstract]","author":"Szalewski","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0224","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-019-08755-8","article-title":"The relationship between hypermobile Ehlers-Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS)","volume":"58","author":"Kohn","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-021-01277-1","article-title":"Neuropsychological assessment in autism spectrum disorder","volume":"23","author":"Braconnier","year":"2021","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0226","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/aur.2670","article-title":"Sensory features in autism: findings from a large population-based surveillance system","volume":"15","author":"Kirby","year":"2022","journal-title":"Autism Res"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0227","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/aur.2628","article-title":"Prevalence of autism spectrum disorder in a large, diverse metropolitan area: variation by sociodemographic factors","volume":"15","author":"Shenouda","year":"2022","journal-title":"Autism Res"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0228","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/aur.2831","article-title":"The role of intellectual disability with autism spectrum disorder and the documented cooccurring conditions: a population-based study","volume":"15","author":"Etyemez","year":"2022","journal-title":"Autism Res"},{"key":"10.1016\/j.anai.2023.10.032_bib0229","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2015.03.086","article-title":"Mast cells, brain inflammation and autism","volume":"778","author":"Theoharides","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"15","key":"10.1016\/j.anai.2023.10.032_bib0231","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.3390\/ijms20153611","article-title":"Mast cells, stress, fear and autism spectrum disorder","volume":"20","author":"Theoharides","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0232","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/039463200902200401","article-title":"Autism spectrum disorders and mastocytosis","volume":"22","author":"Theoharides","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0233","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jaci.2019.12.899","article-title":"How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis","volume":"145","author":"Ravn","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"6301","key":"10.1016\/j.anai.2023.10.032_bib0234","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.aag3194","article-title":"Maternal immune activation: implications for neuropsychiatric disorders","volume":"353","author":"Estes","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.anai.2023.10.032_bib0235","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbi.2015.02.001","article-title":"Immune mediated conditions in autism spectrum disorders","volume":"46","author":"Zerbo","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0236","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpedi.159.2.151","article-title":"Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study","volume":"159","author":"Croen","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0237","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/088307389901400608","article-title":"Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism","volume":"14","author":"Comi","year":"1999","journal-title":"J Child Neurol"},{"issue":"16","key":"10.1016\/j.anai.2023.10.032_bib0238","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1017\/S0033291720001580","article-title":"Maternal immune-related conditions during pregnancy may be a risk factor for neuropsychiatric problems in offspring throughout childhood and adolescence","volume":"51","author":"Patel","year":"2021","journal-title":"Psychol Med"},{"issue":"6519","key":"10.1016\/j.anai.2023.10.032_bib0239","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.aba0864","article-title":"Fetal mast cells mediate postnatal allergic responses dependent on maternal IgE","volume":"370","author":"Msallam","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.114.222505","article-title":"Targeting IL-33 in autoimmunity and inflammation","volume":"354","author":"Theoharides","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.anai.2023.10.032_bib0241","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2431-12-89","article-title":"Perinatal stress, brain inflammation and risk of autism-review and proposal","volume":"12","author":"Angelidou","year":"2012","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.anai.2023.10.032_bib0242","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fncel.2017.00190","article-title":"Effect of neuroinflammation on synaptic organization and function in the developing brain: implications for neurodevelopmental and neurodegenerative disorders","volume":"11","author":"Mottahedin","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0243","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.22620","article-title":"Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults","volume":"71","author":"Hagberg","year":"2012","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0244","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12974-023-02805-x","article-title":"Progressive inflammation reduces high-frequency EEG activity and cortical dendritic arborisation in late gestation fetal sheep","volume":"20","author":"Kelly","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"37","key":"10.1016\/j.anai.2023.10.032_bib0245","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1523\/JNEUROSCI.1176-18.2018","article-title":"Mast cells in the developing brain determine adult sexual behavior","volume":"38","author":"Lenz","year":"2018","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0246","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4168\/aair.2013.5.5.315","article-title":"Allergic diseases in preschoolers are associated with psychological and behavioural problems","volume":"5","author":"Chang","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0247","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1542\/peds.2007-2361","article-title":"American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders","volume":"120","author":"Johnson","year":"2007","journal-title":"Pediatrics."},{"issue":"9920","key":"10.1016\/j.anai.2023.10.032_bib0248","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lai","year":"2014","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0249","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.2017.17812","article-title":"Prevalence of autism spectrum disorder among US children and adolescents, 2014-2016","volume":"319","author":"Xu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2023.10.032_bib0251","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/B978-0-444-52002-9.00023-1","article-title":"Autism and related disorders","volume":"106","author":"McPartland","year":"2012","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.anai.2023.10.032_bib0252","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpeds.2015.12.063","article-title":"Comorbidity of atopic disorders with autism spectrum disorder and attention deficit\/hyperactivity disorder","volume":"171","author":"Liao","year":"2016","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0253","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinthera.2013.04.009","article-title":"Is a subtype of autism an allergy of the brain?","volume":"35","author":"Theoharides","year":"2013","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0263","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/aur.2680","article-title":"Association between atopic diseases and neurodevelopmental disabilities in a longitudinal birth cohort","volume":"15","author":"Qu","year":"2022","journal-title":"Autism Res"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0264","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41398-022-02185-5","article-title":"Eczema and related atopic diseases are associated with increased symptom severity in children with autism spectrum disorder","volume":"12","author":"Jameson","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0268","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0279","article-title":"Association of food allergy and other allergic conditions with autism spectrum disorder in children","volume":"1","author":"Xu","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0269","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/aur.2106","article-title":"Parent-reported prevalence of food allergies in children with autism spectrum disorder: national health interview survey, 2011-2015","volume":"12","author":"Tan","year":"2019","journal-title":"Autism Res"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0270","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/1028415X.2018.1464819","article-title":"Diet: the keystone of autism spectrum disorder?","volume":"22","author":"Peretti","year":"2019","journal-title":"Nutr Neurosci"},{"issue":"1-2","key":"10.1016\/j.anai.2023.10.032_bib0271","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2013.04.003","article-title":"The possible relationship between allergic manifestations and elevated serum levels of brain specific auto-antibodies in autistic children","volume":"261","author":"Mostafa","year":"2013","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0272","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"Cortes Rivera","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0273","first-page":"741","article-title":"Chronic fatigue syndrome: diagnosis and treatment","volume":"86","author":"Yancey","year":"2012","journal-title":"Am Fam Phys"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0275","first-page":"75","article-title":"Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome\/myalgic encephalomyelitis patients","volume":"35","author":"Nguyen","year":"2017","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0276","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.mayocp.2021.07.004","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: essentials of diagnosis and management","volume":"96","author":"Bateman","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"20","key":"10.1016\/j.anai.2023.10.032_bib0277","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.3390\/jcm10204786","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): an overview","volume":"10","author":"Deumer","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.anai.2023.10.032_bib0278","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in post-COVID-19 Syndrome: a systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0279","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurpub\/ckp113","article-title":"Fatigue and chronic fatigue syndrome-like complaints in the general population","volume":"20","author":"van't Leven","year":"2010","journal-title":"Eur J Public Health"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0280","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.clinthera.2018.12.016","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia: definitions, similarities, and differences","volume":"41","author":"Natelson","year":"2019","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0281","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11065-005-3588-2","article-title":"Chronic fatigue syndrome: the need for subtypes","volume":"15","author":"Jason","year":"2005","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0282","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pec.2011.04.016","article-title":"A review and meta-synthesis of qualitative studies on myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"86","author":"Anderson","year":"2012","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0283","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.PSY.0000033125.08272.A9","article-title":"Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis","volume":"65","author":"Ciccone","year":"2003","journal-title":"Psychosom Med"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0284","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/ijerph19042052","article-title":"Prevalence of Aspergillus-derived mycotoxins (ochratoxin, aflatoxin, and gliotoxin) and their distribution in the urinalysis of ME\/CFS patients","volume":"19","author":"Wu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0285","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.jcp.0000148026.86483.4f","article-title":"Brain cytokines and neuropsychiatric disorders","volume":"24","author":"Theoharides","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0286","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome - Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0287","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tox.2008.01.022","article-title":"Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME)","volume":"247","author":"Dietert","year":"2008","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0288","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.bbi.2012.08.009","article-title":"Fatigue, brain, behavior, and immunity: summary of the 2012 Named Series on fatigue","volume":"26","author":"Bower","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0289","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2967\/jnumed.113.131045","article-title":"Neuroinflammation in patients with chronic fatigue syndrome\/myalgic encephalomyelitis: an \u00b9\u00b9C-(R)-PK11195 PET Study","volume":"55","author":"Nakatomi","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.anai.2023.10.032_bib0290","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9006487","article-title":"A review of routine laboratory biomarkers for the detection of severe COVID-19 disease","volume":"2022","author":"Keykavousi","year":"2022","journal-title":"Int J Anal Chem"},{"key":"10.1016\/j.anai.2023.10.032_bib0291","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042921-112837","article-title":"Cytokine storm syndrome","volume":"74","author":"Cron","year":"2023","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0292","first-page":"138","article-title":"NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes","volume":"14","author":"Dutta","year":"2022","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.anai.2023.10.032_bib0293","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221115316","article-title":"COVID-19: clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: a review","volume":"36","author":"Rasool","year":"2022","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.anai.2023.10.032_bib0294","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jare.2021.11.013","article-title":"Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"40","author":"Sukocheva","year":"2022","journal-title":"J Adv Res"},{"key":"10.1016\/j.anai.2023.10.032_bib0295","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1479-5876-7-96","article-title":"Plasma cytokines in women with chronic fatigue syndrome","volume":"7","author":"Fletcher","year":"2009","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0296","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000336803","article-title":"Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis\/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis\/chronic fatigue syndrome than in depression","volume":"81","author":"Maes","year":"2012","journal-title":"Psychother Psychosom"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0297","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/CVI.00527-13","article-title":"Exercise and sleep deprivation do not change cytokine expression levels in patients with chronic fatigue syndrome","volume":"20","author":"Nakamura","year":"2013","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.anai.2023.10.032_bib0298","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpsycho.2017.09.009","article-title":"Depression, evening salivary cortisol and inflammation in chronic fatigue syndrome: a psychoneuroendocrinological structural regression model","volume":"131","author":"Milrad","year":"2018","journal-title":"Int J Psychophysiol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0299","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/s12967-020-02560-0","article-title":"Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis\/chronic fatigue syndrome: a pilot study","volume":"18","author":"Giloteaux","year":"2020","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0300","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.bbi.2012.06.006","article-title":"Biomarkers for chronic fatigue","volume":"26","author":"Klimas","year":"2012","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0301","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41591-022-01952-7","article-title":"Author Correction: unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"issue":"7828","key":"10.1016\/j.anai.2023.10.032_bib0302","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/d41586-020-02796-2","article-title":"Long COVID: let patients help define long-lasting COVID symptoms","volume":"586","year":"2020","journal-title":"Nature"},{"issue":"7833","key":"10.1016\/j.anai.2023.10.032_bib0303","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/d41586-020-03136-0","article-title":"Long COVID: don't consign ME\/CFS to history","volume":"587","author":"White","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0304","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JAD-180786","article-title":"Glia maturation factor and mast cell-dependent expression of inflammatory mediators and proteinase activated Receptor-2 in neuroinflammation","volume":"66","author":"Kempuraj","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0305","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12967-021-03143-3","article-title":"An attempt to explain the neurological symptoms of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"19","author":"Wirth","year":"2021","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0306","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12967-022-03346-2","article-title":"Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME\/CFS)","volume":"20","author":"Haffke","year":"2022","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0307","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/medicina58010028","article-title":"Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"58","author":"Campen","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.anai.2023.10.032_bib0308","article-title":"Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in Long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"9","author":"Vernon","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0309","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s10020-022-00548-8","article-title":"Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism","volume":"28","author":"Patel","year":"2022","journal-title":"Mol Med"},{"key":"10.1016\/j.anai.2023.10.032_bib0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928945","article-title":"Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"13","author":"Gravelsina","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0311","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12967-022-03682-3","article-title":"Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0312","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.clinthera.2019.01.016","article-title":"Fatigue in mastocytosis: a case series","volume":"41","author":"Vikse","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.anai.2023.10.032_bib0313","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2016.03.013","article-title":"Mastocytosis in adulthood and neuropsychiatric disorders","volume":"174","author":"Georgin-Lavialle","year":"2016","journal-title":"Transl Res"},{"issue":"29","key":"10.1016\/j.anai.2023.10.032_bib0314","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1097\/MD.0000000000001211","article-title":"Increased risk of chronic fatigue syndrome following atopy: a population-based study","volume":"94","author":"Yang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"7472","key":"10.1016\/j.anai.2023.10.032_bib0315","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/bmj.38258.507928.55","article-title":"Childhood predictors of self reported chronic fatigue syndrome\/myalgic encephalomyelitis in adults: national birth cohort study","volume":"329","author":"Viner","year":"2004","journal-title":"BMJ"},{"issue":"5 Pt 1","key":"10.1016\/j.anai.2023.10.032_bib0316","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0091-6749(88)90933-5","article-title":"Allergy and the chronic fatigue syndrome","volume":"81","author":"Straus","year":"1988","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0317","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12967-019-1888-1","article-title":"Increased risk of chronic fatigue syndrome following psoriasis: a nationwide population-based cohort study","volume":"17","author":"Tsai","year":"2019","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0319","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1111\/ejn.15828","article-title":"Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis\/chronic fatigue syndrome stimulates human microglia to release IL-1\u03b2","volume":"56","author":"Tsilioni","year":"2022","journal-title":"Eur J Neurosci"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0320","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","article-title":"Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0321","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1124\/jpet.117.240564","article-title":"Methoxyluteolin inhibits neuropeptide-stimulated proinflammatory mediator release via mTOR activation from human mast cells","volume":"361","author":"Patel","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0322","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1094\/PHYTO-02-15-0040-R","article-title":"Candidatus Liberibacter solanacearum\u2019 titers in and infection effects on potato tuber chemistry of promising germplasm exhibiting tolerance to zebra chip disease","volume":"105","author":"Wallis","year":"2015","journal-title":"Phytopathology"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0323","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2666-7568(21)00062-3","article-title":"Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials","volume":"2","author":"Mannick","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.anai.2023.10.032_bib0324","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175301","article-title":"Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain","volume":"934","author":"Morawe","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.anai.2023.10.032_bib0325","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1005631","article-title":"Mechanistic target of rapamycin signaling in human nervous system development and disease","volume":"15","author":"Girodengo","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0326","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","article-title":"Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell Biosci"},{"key":"10.1016\/j.anai.2023.10.032_bib0327","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105311","article-title":"Adiukwu PC. MTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis","volume":"155","author":"Rapaka","year":"2022","journal-title":"Neurochem Int"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0328","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/nn.3546","article-title":"mTOR complexes in neurodevelopmental and neuropsychiatric disorders","volume":"16","author":"Costa-Mattioli","year":"2013","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0329","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.3390\/ijms19082226","article-title":"mTOR-related brain dysfunctions in neuropsychiatric disorders","volume":"19","author":"Ryskalin","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0330","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","article-title":"The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder","volume":"35","author":"Jernigan","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0331","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of mTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0332","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cbf.3692","article-title":"Mammalian target of rapamycin (mTOR) signaling pathway and traumatic brain injury: a novel insight into targeted therapy","volume":"40","author":"Movahedpour","year":"2022","journal-title":"Cell Biochem Funct"},{"issue":"8","key":"10.1016\/j.anai.2023.10.032_bib0333","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1007\/s12035-021-02390-1","article-title":"The mTOR\/NF- \u03baB pathway mediates neuroinflammation and synaptic plasticity in diabetic encephalopathy","volume":"58","author":"Xu","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0334","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14715\/cmb\/2022.68.10.12","article-title":"Evaluating the value of p70S6K and mTOR signaling pathway in monitoring exercise-induced central fatigue in rats","volume":"68","author":"He","year":"2022","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0335","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"Brodin","year":"2021","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0336","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine Storm","volume":"80","author":"Ye","year":"2020","journal-title":"J Infectol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0337","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0338","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0339","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0340","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/hmg\/4.4.751","article-title":"Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome","volume":"4","author":"Zhang","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.anai.2023.10.032_bib0341","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0342","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.934492","article-title":"COVID-19 and the immune system","volume":"69","author":"Paces","year":"2020","journal-title":"Physiol Res"},{"key":"10.1016\/j.anai.2023.10.032_bib0343","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0344","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0345","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0346","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0347","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anai.2023.10.032_bib0348","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0349","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2020.09.016","article-title":"Highways to hell: mechanism-based management of cytokine storm syndromes","volume":"146","author":"Canna","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0350","article-title":"Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19","volume":"6","author":"Scozzi","year":"2021","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0351","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/biof.1633","article-title":"COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin","volume":"46","author":"Theoharides","year":"2020","journal-title":"BioFactors"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0352","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.anai.2020.11.003","article-title":"Potential association of mast cells with coronavirus disease 2019","volume":"126","author":"Theoharides","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0353","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/biof.1726","article-title":"Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue","volume":"47","author":"Theoharides","year":"2021","journal-title":"BioFactors"},{"key":"10.1016\/j.anai.2023.10.032_bib0354","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175169","article-title":"Mast cells promote viral entry of SARS-CoV-2 via formation of chymase\/spike protein complex","volume":"930","author":"Liu","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0123","article-title":"Mast cell activation syndrome and the link with Long COVID","volume":"83","author":"Arun","year":"2022","journal-title":"Br J Hosp Med (Lond)"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0356","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3390\/cells10102754","article-title":"Basophils and mast cells in COVID-19 pathogenesis","volume":"10","author":"Murdaca","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.anai.2023.10.032_bib0357","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijid.2020.09.016","article-title":"Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome","volume":"100","author":"Afrin","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.anai.2023.10.032_bib0358","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijid.2021.09.043","article-title":"Mast cell activation symptoms are prevalent in Long-COVID","volume":"112","author":"Weinstock","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"40","key":"10.1016\/j.anai.2023.10.032_bib0359","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.2174\/1381612829666221027114123","article-title":"Mast cell's role in cytokine release syndrome and related manifestations of COVID-19 disease","volume":"28","author":"Ozdemir","year":"2022","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.anai.2023.10.032_bib0361","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.650331","article-title":"Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody","volume":"12","author":"Gebremeskel","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0367","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12931-022-02284-3","article-title":"Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients","volume":"23","author":"Budnevsky","year":"2022","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.anai.2023.10.032_bib0368","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/all.15293","article-title":"Mast cells in lung damage of COVID-19 autopsies: a descriptive study","volume":"77","author":"Schaller","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0371","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID-19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0372","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","article-title":"Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports","volume":"17","author":"Najjar","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.anai.2023.10.032_bib0373","doi-asserted-by":"crossref","first-page":"e13591","DOI":"10.1111\/dth.13591","article-title":"Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders","volume":"33","author":"Singh","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0374","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.13114","article-title":"The nervous system during COVID-19: caught in the crossfire","volume":"311","author":"Natale","year":"2022","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib0375","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/eji.202149475","article-title":"Autoimmunity and SARS-CoV-2 infection: unraveling the link in neurological disorders","volume":"52","author":"Latorre","year":"2022","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0376","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2215-0366(20)30462-4","article-title":"Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"10.1016\/j.anai.2023.10.032_bib0377","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jama.2020.14294","article-title":"Psychiatry and COVID-19","volume":"324","author":"Ongur","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2023.10.032_bib0378","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbi.2020.05.048","article-title":"COVID-19 pandemic and mental health consequences: systematic review of the current evidence","volume":"89","author":"Vindegaard","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0379","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1056\/NEJMp2008017","article-title":"Mental health and the Covid-19 pandemic","volume":"383","author":"Pfefferbaum","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0380","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2215-0366(20)30046-8","article-title":"Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed","volume":"7","author":"Xiang","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0381","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biopsych.2020.05.012","article-title":"The COVID-19 pandemic: setting the mental health research agenda","volume":"88","author":"Gordon","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.anai.2023.10.032_bib0382","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1029842","article-title":"Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints","volume":"14","author":"Ariza","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"10270","key":"10.1016\/j.anai.2023.10.032_bib0383","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0384","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/10408363.2020.1860895","article-title":"COVID-19: from an acute to chronic disease? Potential long-term health consequences","volume":"58","author":"Higgins","year":"2021","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0385","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2021.01.004","article-title":"Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study","volume":"82","author":"Moreno-Perez","year":"2021","journal-title":"J Infectol"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0386","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240784","article-title":"Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection","volume":"15","author":"Townsend","year":"2020","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.anai.2023.10.032_bib0387","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3390\/cells11162480","article-title":"Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients","volume":"11","author":"Zingaropoli","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.anai.2023.10.032_bib0388","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1038\/s41467-022-34068-0","article-title":"Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study","volume":"13","author":"Etter","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.anai.2023.10.032_bib0389","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070379","article-title":"Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations","volume":"13","author":"Bonetto","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0390","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMc2033369","article-title":"Microvascular injury in the brains of patients with Covid-19","volume":"384","author":"Lee","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0391","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1093\/brain\/awac321","article-title":"Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses","volume":"145","author":"Needham","year":"2022","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.anai.2023.10.032_bib0392","article-title":"Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses","volume":"6","author":"Files","year":"2021","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.anai.2023.10.032_bib0393","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/pmrj.12684","article-title":"Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients","volume":"13","author":"Herrera","year":"2021","journal-title":"PM R"},{"issue":"34","key":"10.1016\/j.anai.2023.10.032_bib0394","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024358118","article-title":"Redox imbalance links COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"118","author":"Paul","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.anai.2023.10.032_bib0395","first-page":"1633","article-title":"COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome?","volume":"34","author":"Theoharides","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0396","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0397","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1744666X.2019.1596800","article-title":"Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?","volume":"15","author":"Theoharides","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"issue":"18","key":"10.1016\/j.anai.2023.10.032_bib0398","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJMc2302460","article-title":"Humoral innate immunity and acute-phase proteins","volume":"388","author":"Theoharides","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0399","doi-asserted-by":"crossref","first-page":"9487","DOI":"10.3390\/ijms24119487","article-title":"Recombinant SARS-CoV-2 spike protein stimulates secretion of chymase, tryptase, and IL-1\u03b2 from human mast cells, augmented by IL-33","volume":"24","author":"Tsilioni","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0400","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1007\/s12035-023-03493-7","article-title":"Recombinant SARS-CoV-2 spike protein and its receptor binding domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells","volume":"60","author":"Tsilioni","year":"2023","journal-title":"Mol Neurobiol"},{"issue":"10","key":"10.1016\/j.anai.2023.10.032_bib412","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","article-title":"SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)","volume":"24","author":"Proal","year":"2023","journal-title":"Nat. Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib413","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1093\/cid\/ciac722","article-title":"Persistent circulating severe acute respiratory syndrome coronavirus 2 spike Is associated with post-acute coronavirus disease 2019 sequelae","volume":"76","author":"Swank","year":"2023","journal-title":"Clinical Infectious Diseases\u202f: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.anai.2023.10.032_bib414","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746021","article-title":"Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection","volume":"12","author":"Patterson","year":"2022","journal-title":"Front. Immunol"},{"issue":"15","key":"10.1016\/j.anai.2023.10.032_bib415","article-title":"Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses","volume":"6","author":"Files","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.anai.2023.10.032_bib0401","article-title":"SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19","author":"Rong","year":"2023","journal-title":"BioRxiv"},{"issue":"11","key":"10.1016\/j.anai.2023.10.032_bib0402","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/acn3.51631","article-title":"Genetics of COVID-19 and myalgic encephalomyelitis\/chronic fatigue syndrome: a systematic review","volume":"9","author":"Tziastoudi","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"suppl 1","key":"10.1016\/j.anai.2023.10.032_bib0403","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/clinids\/18.Supplement_1.S154","article-title":"Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome","volume":"18","author":"Keller","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anai.2023.10.032_bib0404","doi-asserted-by":"crossref","DOI":"10.1177\/26331055221114817","article-title":"At the Root of 3 \"Long\" Diseases: Persistent Antigens Inflicting Chronic Damage on the Brain and Other Organs in Gulf War Illness, Long-COVID-19, and Chronic Fatigue Syndrome","volume":"17","author":"James","year":"2022","journal-title":"Neurosci Insights"},{"issue":"3","key":"10.1016\/j.anai.2023.10.032_bib0405","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome?","volume":"59","author":"Theoharides","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.anai.2023.10.032_bib0406","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102672","article-title":"Modeling neuro-immune interactions using human pluripotent stem cells","volume":"79","author":"Garcia-Epelboim","year":"2023","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.anai.2023.10.032_bib0407","doi-asserted-by":"crossref","unstructured":"Yip S, Wang N, Sugimura R. Give them vasculature and immune cells - how to fill the gap of organoids [e-pub ahead of print]. Cells Tissues Organs. https:\/\/doi.org\/10.1159\/000529431, accessed October 17, 2023.","DOI":"10.1159\/000529431"},{"issue":"2","key":"10.1016\/j.anai.2023.10.032_bib0408","doi-asserted-by":"crossref","first-page":"e2430","DOI":"10.1002\/rmv.2430","article-title":"Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system","volume":"33","author":"Ostermann","year":"2023","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.anai.2023.10.032_bib0409","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.3390\/ijms24065275","article-title":"KIT D816V mast cells derived from induced pluripotent stem cells recapitulate systemic mastocytosis transcriptional profile","volume":"24","author":"de Toledo","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623013972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623013972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:55:54Z","timestamp":1711932954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623013972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":413,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1081120623013972"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.10.032","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}